|
HRTX | Heron Therapeutics, Inc. /de/ |
|
|
HRTX | Heron Therapeutics, Inc. /de/ |
| Pharmaceutical Preparations |
| Book value per $ invested | $ -0.36 |
| Leverage | 113.64% |
| Market Cap | $ 267.1m |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -7.8m |
| Margin | -5.35% |
Heron Therapeutics, Inc., a biotechnology company, is dedicated to developing treatments to address unmet medical needs. The company is headquartered in San Diego, California.